l 703606 has been researched along with gamma-aminobutyric acid in 1 studies
| Studies (l 703606) | Trials (l 703606) | Recent Studies (post-2010) (l 703606) | Studies (gamma-aminobutyric acid) | Trials (gamma-aminobutyric acid) | Recent Studies (post-2010) (gamma-aminobutyric acid) |
|---|---|---|---|---|---|
| 74 | 0 | 12 | 40,215 | 1,423 | 9,631 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett-Jolley, R; Gent, TC; Morris, R; Womack, MD | 1 |
1 other study(ies) available for l 703606 and gamma-aminobutyric acid
| Article | Year |
|---|---|
Substance P targets sympathetic control neurons in the paraventricular nucleus.
Topics: Animals; Blood Pressure; Enzyme Activators; Enzyme Inhibitors; gamma-Aminobutyric Acid; Heart Rate; Kidney; Male; Neural Inhibition; Neurons; Organ Culture Techniques; Paraventricular Hypothalamic Nucleus; Patch-Clamp Techniques; Protein Kinase C; Quinuclidines; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, Neurokinin-1; Substance P; Sympathetic Nervous System | 2007 |